RAMM Pharma (XCNQ:RAMM) Debt-to-Asset : 0.01 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is RAMM Pharma Debt-to-Asset?

RAMM Pharma XCNQ:RAMM Debt-to-Asset is 0.01 as of Apr. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2026 was C$0.04 Mil. RAMM Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2026 was C$0.00 Mil. RAMM Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Apr. 2026 was C$7.13 Mil. RAMM Pharma's debt to asset for the quarter that ended in Apr. 2026 was 0.01.

RAMM Pharma  (XCNQ:RAMM) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

RAMM Pharma Debt-to-Asset Related Terms

RAMM Pharma Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Debt-to-Asset Chart

RAMM Pharma Annual Data
Trend Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Debt-to-Asset
Get a 7-Day Free Trial 0.00 0.02 0.01 0.01 0.01

RAMM Pharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.01 0.01 0.01

XCNQ:RAMM vs ZTS: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RAMM Pharma Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's Debt-to-Asset falls into.


RAMM Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

RAMM Pharma's Debt-to-Asset for the fiscal year that ended in Oct. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.068962 + 0.011432) / 9.269971
=0.01

RAMM Pharma's Debt-to-Asset for the quarter that ended in Apr. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.044171 + 0) / 7.126986
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.01 mean?
RAMM Pharma (XCNQ:RAMM) has a Debt-to-Asset of 0.01 as of Apr. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Debt-to-Asset too high?
RAMM Pharma's current Debt-to-Asset is 0.01.
How does RAMM Pharma's Debt-to-Asset compare to ZTS?
RAMM Pharma's Debt-to-Asset of 0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Debt-to-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Debt-to-Asset is 0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Debt-to-Asset is 0.01 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.